Scroll To Top
Health

FDA approves
nausea drug for cancer patients

FDA approves
nausea drug for cancer patients

Sorry to interrupt...
But we wanted to take a moment to thank you for reading. Your support makes original LGBTQ+ reporting possible. Help us hold Trump accountable.

The Food and Drug Administration on Wednesday approved Merck's antinausea medication Emend for use in conjunction with other antinausea drugs to treat cancer patients receiving chemotherapy. Emend, made by Merck, was shown in a study of breast cancer patients to significantly reduce the chances for nausea and vomiting when added to a regimen of already-approved antinausea drugs. Many of the women studied reported a complete lack of nausea when taking regimens including Emend. (Advocate.com)

The Advocates with Sonia BaghdadyOut / Advocate Magazine - Alan Cumming and Jake Shears

From our Sponsors

Most Popular

Latest Stories

Outtraveler Staff